＜＜BACK

NEXT＞＞

Vol. 40 Suppl. 2 2012

■Symposium 1：How to Conduct International Collaboration Clinical Study in Oncology

Where Japan Clinical Oncology Group (JCOG) Has Been and Where JCOG Is Going

H. Fukuda

Jpn Pharmacol Ther 2012　40(s2) s90-3

---

The Establishment of West Japan Oncology Group (WJOG)，and Current Situation and Prospect of It

S. Nakamura

Jpn Pharmacol Ther 2012　40(s2) s94-7

---

The Past and Future of Investigator-Initiated Clinical Trials Conducted by Japanese Gynecologic Oncology Group (JGOG)

K. Ochiai

Jpn Pharmacol Ther 2012　40(s2) s98-101

---

The Past and Future of Japan Adult Leukemia Study Group (JALSG)

T. Naoe

Jpn Pharmacol Ther 2012　40(s2) s102-5

---

The Current Status and Issues of Comprehensive Support Project for Oncology Research-Breast Cancer

H. Mukai

Jpn Pharmacol Ther 2012　40(s2) s106-8

Clinical Trial and ICH Harmonized Tripartite Guideline: From the Point of Structure and Content of Clinical Study Reports E3

H. Sakai, et al.

Jpn Pharmacol Ther 2012　40(s2) s109-12

---

Enhancing Drug Safety Evaluation: from "Formality" to "Science"　

O. Komiyama

Jpn Pharmacol Ther 2012　40(s2) s113-5

■REPORT

Report from Subgroup Education, Training, Infrastructure and Patient Involvement under OECD GSF Working Group to Facilitate International Cooperation in Non-Commercial Clinical Trials　

Øyvind Melien, et al.

Jpn Pharmacol Ther 2012　40(s2) s137-82